发明名称 METHOD OF ASSESSING REPERFUSION AFTER THROMBOLYTIC THERAPY
摘要 <p>The present invention is a method of diagnosing the presence of a persistent occlusion in a myocardial infarct patient undergoing thrombolytic therapy. The method comprises detecting a series of five variables from the patient and then generating the probability of the presence of a persistent occlusion from those variables. The first variable comprises a serum creatine kinase MB (CK-MB) level (10) from a patient at the onset of thrombolytic therapy. The second variable comprises a second CK-MB level (20) in the patient at a predetermined time after the onset of thrombolytic therapy. The third variable comprises the presence or absence of chest pain (50) a predetermined time after the onset of thrombolytic therapy. The fourth variable comprises the serum myoglobin level (30) in the patient at a predetermined time after the onset of thrombolytic therapy. In a preferred embodiment of the present invention, the second, third and fourth variables are detected within 30 minutes of each other and within about 1 hour to 3 hours after the initial variable is detected. In an alternate embodiment a fifth variable reflecting the time from onset of chest pain to the beginning of thrombolytic therapy is included in the regression model.</p>
申请公布号 WO1997006725(A1) 申请公布日期 1997.02.27
申请号 US1996013264 申请日期 1996.08.16
申请人 发明人
分类号 主分类号
代理机构 代理人
主权项
地址
您可能感兴趣的专利